1. Home
  2. KTTA vs SNAX Comparison

KTTA vs SNAX Comparison

Compare KTTA & SNAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • SNAX
  • Stock Information
  • Founded
  • KTTA 2020
  • SNAX 2017
  • Country
  • KTTA United States
  • SNAX United States
  • Employees
  • KTTA N/A
  • SNAX N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • SNAX Packaged Foods
  • Sector
  • KTTA Health Care
  • SNAX Consumer Staples
  • Exchange
  • KTTA Nasdaq
  • SNAX Nasdaq
  • Market Cap
  • KTTA 3.2M
  • SNAX 2.7M
  • IPO Year
  • KTTA 2021
  • SNAX N/A
  • Fundamental
  • Price
  • KTTA $2.48
  • SNAX $0.75
  • Analyst Decision
  • KTTA
  • SNAX
  • Analyst Count
  • KTTA 0
  • SNAX 0
  • Target Price
  • KTTA N/A
  • SNAX N/A
  • AVG Volume (30 Days)
  • KTTA 43.9K
  • SNAX 128.6K
  • Earning Date
  • KTTA 11-13-2024
  • SNAX 11-13-2024
  • Dividend Yield
  • KTTA N/A
  • SNAX N/A
  • EPS Growth
  • KTTA N/A
  • SNAX N/A
  • EPS
  • KTTA N/A
  • SNAX N/A
  • Revenue
  • KTTA N/A
  • SNAX $19,364,939.00
  • Revenue This Year
  • KTTA N/A
  • SNAX $30.31
  • Revenue Next Year
  • KTTA N/A
  • SNAX N/A
  • P/E Ratio
  • KTTA N/A
  • SNAX N/A
  • Revenue Growth
  • KTTA N/A
  • SNAX N/A
  • 52 Week Low
  • KTTA $2.20
  • SNAX $0.55
  • 52 Week High
  • KTTA $9.25
  • SNAX $2.33
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 38.84
  • SNAX 50.42
  • Support Level
  • KTTA $2.20
  • SNAX $0.70
  • Resistance Level
  • KTTA $2.61
  • SNAX $0.77
  • Average True Range (ATR)
  • KTTA 0.28
  • SNAX 0.08
  • MACD
  • KTTA -0.03
  • SNAX 0.01
  • Stochastic Oscillator
  • KTTA 24.35
  • SNAX 45.54

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.

About SNAX Stryve Foods Inc.

Stryve Foods Inc is a healthy snacking company that manufactures, markets, and sells differentiated healthy snacking products. The company offers convenient snacks that are lower in sugar and carbohydrates and higher in protein than other snacks.

Share on Social Networks: